STOCK TITAN
  1. Home
  2. Sec-filings
  3. LQDA
  4. [144] Liquidia Corp SEC Filing

Multiple 10b5-1 sales reported for LQDA (ticker LQDA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Serendipity Biopharma LLC and affiliated parties reported multiple Rule 144/10b5-1 dispositions of Common Stock. The excerpt lists scheduled 10b5-1 sales and Rule 144 sales executed between 04/09/2026 and 05/19/2026, with individual transactions commonly of 25,000 shares and reported dollar amounts per trade. The filings identify a broker-dealer intermediary as Morgan Stanley Smith Barney LLC.

Positive

  • None.

Negative

  • None.

Insights

Multiple routine 10b5-1/Rule 144 dispositions were executed across April–May 2026.

Records show repeated scheduled sales labeled as "10b5-1 Sales for SERENDIPITY BIOPHARMA LLC" and one sale attributed to Roger Jeffs. Most trades are sized at 25,000 shares, with varying gross proceeds reported per trade.

The activity is presented as broker-facilitated dispositions via Morgan Stanley Smith Barney LLC. Timing and pricing indicate executions across several dates; these are routine dispositions under specified plans rather than ad hoc open-market trades.

Repeated trade size 25,000 shares multiple 10b5-1 sales between 04/09/2026 and 05/19/2026
Example proceeds $1,466,142.50 proceeds reported for 25,000-share sale on 05/19/2026
Example proceeds $1,419,320.00 proceeds reported for 25,000-share sale on 05/18/2026
Larger single sale 32,744 shares sale attributed to Roger Jeffs on 04/13/2026
Smaller single sale 3,300 shares 10b5-1 sale on 04/14/2026 with proceeds $132,000.00
10b5-1 regulatory
"10b5-1 Sales for SERENDIPITY BIOPHARMA LLC 419 Davis Drive"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Broker-dealer financial
"Morgan Stanley Smith Barney LLC Executive Financial Services"
A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR

FAQ

What transactions does the LQDA Form 144 excerpt show?

The excerpt shows multiple Rule 144/10b5-1 dispositions of Common Stock by Serendipity Biopharma LLC and an individual, executed between 04/09/2026 and 05/19/2026 with per-trade share counts and proceeds.

Who acted as the broker-dealer for these reported sales (LQDA)?

The filings identify Morgan Stanley Smith Barney LLC as the broker-dealer intermediary related to the reported Common Stock dispositions in the excerpt.

What are typical trade sizes reported in the excerpt for LQDA?

Many entries show trades of 25,000 shares per transaction; other reported sizes include 32,744, 21,433, and 18,839 shares on specific dates.

Do the entries indicate if sales were pre-arranged under a trading plan?

Transactions are labeled as "10b5-1 Sales," which indicates they were executed under a pre-established trading plan rather than described as one-off discretionary trades.